KEVIN PEREZ: Open Payments
NPI 1578234571 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,846 in 96 payments from 20 companies in 2025. Trend: 2023 $1,928 · 2024 $1,325 · 2025 $1,846
Food & beverage: $1,846
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $341 |
| Novo Nordisk Inc | 12 | $304 |
| Amgen Inc. | 17 | $264 |
| GlaxoSmithKline, LLC. | 17 | $189 |
| Astellas Pharma US Inc | 4 | $92 |
| ABBVIE INC. | 4 | $82 |
| SANOFI-AVENTIS U.S. LLC | 2 | $74 |
| Lilly USA, LLC | 3 | $62 |
| Sumitomo Pharma America, Inc. | 4 | $62 |
| Esperion Therapeutics, Inc. | 3 | $58 |
Products named: NURTEC ODT, EVENITY, ELIQUIS, TRELEGY ELLIPTA, Wegovy, OTEZLA, Rybelsus, Veozah.
Industry payments across FL — which companies pay providers there.
